01 Growing Adoption of Minimally Invasive Neurosurgeries The increasing shift toward minimally invasive neurosurgical techniques is significantly driving the demand for scalp clip systems. These procedures, including endoscopic and robotic-assisted surgeries, offer multiple advantages, such as reduced tissue trauma, minimal blood loss, shorter recovery times, and improved patient outcomes. Scalp clip systems play a crucial role in these interventions by ensuring effective hemostasis and surgical field stability with minimal interference. For instance, a February 2025 National Library of Medicine article highlighted a 2023 survey revealing that 89.11% of hospitals in Latin America and Africa performed ventricular endoscopy, and 61.39% had skull base surgery capabilities. This increasing adoption of neuro-endoscopic procedures is propelling demand for advanced hemostatic solutions like scalp clip systems as hospitals invest in cutting-edge surgical tools to enhance precision and efficiency. The continued integration of robotic-assisted techniques and AI-driven surgical systems will further accelerate the adoption of scalp clip systems, supporting market growth.
September 2025 Medtronic expanded its neurosurgical technology initiatives by integrating advanced surgical solutions across its cranial and neurological care portfolio. The company continued collaborations with healthcare professionals to improve procedural techniques and develop solutions supporting minimally invasive and precision-based neurosurgical interventions.
August 2025 DePuy Synthes strengthened its neurosurgery and cranial fixation business through continued innovation initiatives for surgical fixation systems. The company focused on advancing implantable solutions and procedural technologies designed to support complex cranial surgeries and improve operating room workflows.
July 2025 KLS Martin introduced updates to its craniofacial and neurosurgical fixation product offerings, enhancing its range of surgical clips and fixation technologies. The company continued product development efforts aimed at improving surgical efficiency, precision, and patient outcomes in cranial procedures.
June 2025 Integra LifeSciences expanded its neurosurgical product portfolio through continued commercialization initiatives for advanced cranial fixation and scalp closure solutions. The company focused on strengthening its surgical technologies portfolio by supporting hospitals and surgeons with improved procedural solutions, including products used in cranial and neurosurgical applications.